The U.S. Food and Drug Administration has questioned the efficacy of aspirin in preventing first heart attack or stroke in people who have never had cardiovascular problems. Last week, the FDA has turned down the plea of German drugmaker Bayer AG to change the labeling on packages in order to market aspirin's value in preventing heart attacks in people who have never had cardiovascular … [Read more...]
You are here: Home / Archives for Bayer AG